The Role of Environmental Risk Factors on the Development of Childhood Allergic Rhinitis.
Allison C WuAmber DahlinAlberta L WangPublished in: Children (Basel, Switzerland) (2021)
Environmental factors play an important role in the development and exacerbation of allergic rhinitis (AR) in childhood. Indoor air pollution, such as house dust mites and secondhand smoke, can significantly increase the onset of AR, while pet dander may affect the exacerbation of AR symptoms in children. Furthermore, traffic related air pollution and pollen are outdoor air pollutants that can affect immune competency and airway responsiveness, increasing the risk of AR in children. Climate change has increased AR in children, as growth patterns of allergenic species have changed, resulting in longer pollen seasons. More extreme and frequent weather events also contribute to the deterioration of indoor air quality due to climate change. Additionally, viruses provoke respiratory tract infections, worsening the symptoms of AR, while viral infections alter the immune system. Although viruses and pollution influence development and exacerbation of AR, a variety of treatment and prevention options are available for AR patients. The protective influence of vegetation (greenness) is heavily associated with air pollution mitigation, relieving AR exacerbations, while the use of air filters can reduce allergic triggers. Oral antihistamines and intranasal corticosteroids are common pharmacotherapy for AR symptoms. In this review, we discuss the environmental risk factors for AR and summarize treatment strategies for preventing and managing AR in children.
Keyphrases
- air pollution
- climate change
- particulate matter
- allergic rhinitis
- chronic obstructive pulmonary disease
- young adults
- risk factors
- human health
- lung function
- respiratory tract
- cystic fibrosis
- intensive care unit
- end stage renal disease
- sars cov
- risk assessment
- chronic kidney disease
- physical activity
- newly diagnosed
- depressive symptoms
- prognostic factors
- health risk assessment
- pet imaging
- peritoneal dialysis
- combination therapy
- genetic diversity
- positron emission tomography